Trademark Overview
On Tuesday, November 25, 2025, a trademark application was filed for ZAFBENA with the United States Patent and Trademark Office. The USPTO has given the ZAFBENA trademark a serial number of 99515515. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Monday, March 30, 2026. This trademark is owned by BendaRx Corp.. The ZAFBENA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for use in oncology and pharmaceutical preparations to treat cancer; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of cancer; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical preparations for cellular therapy for the treatment of cancer